Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | ACE | P12821 | 2/20 | 0.56 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.55 |
| ▸ | ECE1 | P42892 | 10/20 | 0.53 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.52 |
| ▸ | IL1RN | P18510 | 1/20 | 0.51 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29379360 | 0.97 | CTSC (0.64) | CTSCMEN1KMT2AACEERAP2 | |
| SCHEMBL29470182 | 0.94 | ACE (0.57) | CTSCMEN1KMT2AACEERAP2 | |
| SCHEMBL30052005 | 0.93 | CTSC (0.69) | CTSCMEN1KMT2AACEERAP2 | |
| SCHEMBL11228707 | 0.91 | CTSC (0.65) | CTSCMEN1KMT2AACEERAP2 | |
| SCHEMBL11228723 | 0.91 | CTSC (0.65) | CTSCMEN1KMT2AACEERAP2 | |
| Hydrochloric Acid SCHEMBL11220807 | 0.91 | CTSC (0.64) | CTSCMEN1KMT2AACEERAP2 | |
| SCHEMBL30051830 | 0.90 | CTSC (0.71) | CTSCMEN1KMT2AACEERAP2 | |
| SCHEMBL7049417 | 0.90 | CTSC (0.73) | CTSCMEN1KMT2AACEECE1 | |
| SCHEMBL13154782 | 0.90 | CTSC (0.73) | CTSCMEN1KMT2AACEECE1 | |
| SCHEMBL7048700 | 0.90 | CTSC (0.73) | CTSCMEN1KMT2AACEECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220128556-A1 | METHODS OF DIAGNOSING DISEASE | 4D Pharma Cork Limited (IE) | 2022-04-28 | — | — | US | disclosed |
| CN-114040986-A | Method of diagnosing disease | 4D制药科克有限公司 | 2022-02-11 | — | — | CN | disclosed |
| EP-3947743-A1 | METHODS OF DIAGNOSING DISEASE | 4D Pharma Cork Limited (IE) | 2022-02-09 | — | — | EP | disclosed |